Next-generation ALS drug silences inherited form of the disease in animal models
NIH-funded researchers delayed signs of amyotrophic lateral sclerosis (ALS) in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results, published in ...
Jul 26, 2018
0
13